These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1275541)

  • 1. Serum creatine phosphokinase in normal newborns.
    Gilboa N; Swanson JR
    Arch Dis Child; 1976 Apr; 51(4):283-5. PubMed ID: 1275541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum creatine kinase in normal newborns (author's transl)].
    Gerbaut L; Francoual C; Macart M
    Arch Fr Pediatr; 1981 Dec; 38(10):743-6. PubMed ID: 7332416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy.
    Folkers K; Nakamura R; Littarru GP; Zellweger H; Brunkhorst JB; Williams CW; Langston JH
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2098-102. PubMed ID: 4525474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy.
    Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ
    N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the activity of creatine phosphokinase for the detection of carriers of Duchenne-type muscular dystrophy in families in the city of Monterrey, Mexico].
    Alvarez Leal M; Ortiz Mariscal JD; Narro Juárez A; Solís Alanís JG; Morales Aguilera A
    Rev Invest Clin; 1990; 42(1):39-45. PubMed ID: 2236973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early clinical and histopathological manifestations in 14 boys showing elevated serum creatine-phosphokinase levels in their first year].
    Guibaud P; Carrier HN; Plauchu H; Lauras B; Jolivet MJ; Robert JM
    J Genet Hum; 1981 Mar; 29(1):71-84. PubMed ID: 7334343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of young female carriers of Duchenne muscular dystrophy].
    Alvarez Leal MA; Morales-Aguilera A
    Arch Invest Med (Mex); 1990; 21(3):269-72. PubMed ID: 2131776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-CPK test. A new diagnostic aid for muscular dystrophy and its carriers?
    Sen S; Das PK
    Eur Neurol; 1978; 17(5):258-64. PubMed ID: 710453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies.
    Zatz M; Shapiro LJ; Campion DS; Oda E; Kaback MM
    J Neurol Sci; 1978 May; 36(3):349-62. PubMed ID: 681967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine phosphokinase (CPK) levels in umbilical cord blood.
    Sabater J; Villalba M
    Clin Chim Acta; 1972 Jan; 36(1):201-6. PubMed ID: 5007701
    [No Abstract]   [Full Text] [Related]  

  • 18. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of creatine phosphokinase and its isoenzymes in normal and stressed neonates.
    Sutton TM; O'Brien JF; Kleinberg F; House RF; Feldt RH
    Mayo Clin Proc; 1981 Mar; 56(3):150-4. PubMed ID: 7206791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoglobinemia in children with progressive muscular dystrophy.
    Ando T; Shimizu T; Kato T; Ohsawa M; Fukuyama Y
    Clin Chim Acta; 1978 Apr; 85(1):17-22. PubMed ID: 647964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.